Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral lymphedema

S. J. Kim, Chung Hwi Yi, O. Y. Kwon

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

There is increasing interest in the health-related quality of life (QOL) of patients with chronic lymphedema. The aim of this study was to ascertain whether complex decongestive therapy (CDT) for upper limb lymphedema results in long-term changes in lymphedema and QOL, and to determine whether the treatment-induced change in the percentage excess volume (PCEV) is correlated with any changes in QOL. Fifty-three patients who had lymphedema were treated with CDT. PCEV and QOL were recorded before and 1 month after CDT, and at a 6-month follow-up visit. PCEV was significantly (p<0.05) decreased at 1 month, but significantly (p<0.05) increased at 6 months compared to 1 month [but still significantly reduced (p<0.05) from baseline]. The QOL scores at 1 and 6 months were significantly higher than the score at baseline, indicating an improvement in the QOL. Significant changes were evident in the single domains of physical functioning, role-physical, mental health, and general health. The change in PCEV was associated with a change in physical functioning, vitality, bodily pain, and general health at 1 and 6 months (p<0.05). This study suggests that QOL significantly improved with upper limb lymphedema during the maintenance phase, which was necessarily correlated with the reduction in limb volume.

Original languageEnglish
Pages (from-to)143-151
Number of pages9
JournalLymphology
Volume40
Issue number3
Publication statusPublished - 2007 Sep 1

Fingerprint

Lymphedema
Edema
Quality of Life
Breast Neoplasms
Upper Extremity
Therapeutics
Health
Mental Health
Extremities
Maintenance
Pain

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Medicine(all)
  • Hematology

Cite this

@article{2fccc2c9ade14ff2b419c316af1b46f6,
title = "Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral lymphedema",
abstract = "There is increasing interest in the health-related quality of life (QOL) of patients with chronic lymphedema. The aim of this study was to ascertain whether complex decongestive therapy (CDT) for upper limb lymphedema results in long-term changes in lymphedema and QOL, and to determine whether the treatment-induced change in the percentage excess volume (PCEV) is correlated with any changes in QOL. Fifty-three patients who had lymphedema were treated with CDT. PCEV and QOL were recorded before and 1 month after CDT, and at a 6-month follow-up visit. PCEV was significantly (p<0.05) decreased at 1 month, but significantly (p<0.05) increased at 6 months compared to 1 month [but still significantly reduced (p<0.05) from baseline]. The QOL scores at 1 and 6 months were significantly higher than the score at baseline, indicating an improvement in the QOL. Significant changes were evident in the single domains of physical functioning, role-physical, mental health, and general health. The change in PCEV was associated with a change in physical functioning, vitality, bodily pain, and general health at 1 and 6 months (p<0.05). This study suggests that QOL significantly improved with upper limb lymphedema during the maintenance phase, which was necessarily correlated with the reduction in limb volume.",
author = "Kim, {S. J.} and Yi, {Chung Hwi} and Kwon, {O. Y.}",
year = "2007",
month = "9",
day = "1",
language = "English",
volume = "40",
pages = "143--151",
journal = "Lymphology",
issn = "0024-7766",
publisher = "International Society of Lymphology",
number = "3",

}

Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral lymphedema. / Kim, S. J.; Yi, Chung Hwi; Kwon, O. Y.

In: Lymphology, Vol. 40, No. 3, 01.09.2007, p. 143-151.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral lymphedema

AU - Kim, S. J.

AU - Yi, Chung Hwi

AU - Kwon, O. Y.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - There is increasing interest in the health-related quality of life (QOL) of patients with chronic lymphedema. The aim of this study was to ascertain whether complex decongestive therapy (CDT) for upper limb lymphedema results in long-term changes in lymphedema and QOL, and to determine whether the treatment-induced change in the percentage excess volume (PCEV) is correlated with any changes in QOL. Fifty-three patients who had lymphedema were treated with CDT. PCEV and QOL were recorded before and 1 month after CDT, and at a 6-month follow-up visit. PCEV was significantly (p<0.05) decreased at 1 month, but significantly (p<0.05) increased at 6 months compared to 1 month [but still significantly reduced (p<0.05) from baseline]. The QOL scores at 1 and 6 months were significantly higher than the score at baseline, indicating an improvement in the QOL. Significant changes were evident in the single domains of physical functioning, role-physical, mental health, and general health. The change in PCEV was associated with a change in physical functioning, vitality, bodily pain, and general health at 1 and 6 months (p<0.05). This study suggests that QOL significantly improved with upper limb lymphedema during the maintenance phase, which was necessarily correlated with the reduction in limb volume.

AB - There is increasing interest in the health-related quality of life (QOL) of patients with chronic lymphedema. The aim of this study was to ascertain whether complex decongestive therapy (CDT) for upper limb lymphedema results in long-term changes in lymphedema and QOL, and to determine whether the treatment-induced change in the percentage excess volume (PCEV) is correlated with any changes in QOL. Fifty-three patients who had lymphedema were treated with CDT. PCEV and QOL were recorded before and 1 month after CDT, and at a 6-month follow-up visit. PCEV was significantly (p<0.05) decreased at 1 month, but significantly (p<0.05) increased at 6 months compared to 1 month [but still significantly reduced (p<0.05) from baseline]. The QOL scores at 1 and 6 months were significantly higher than the score at baseline, indicating an improvement in the QOL. Significant changes were evident in the single domains of physical functioning, role-physical, mental health, and general health. The change in PCEV was associated with a change in physical functioning, vitality, bodily pain, and general health at 1 and 6 months (p<0.05). This study suggests that QOL significantly improved with upper limb lymphedema during the maintenance phase, which was necessarily correlated with the reduction in limb volume.

UR - http://www.scopus.com/inward/record.url?scp=35848969125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848969125&partnerID=8YFLogxK

M3 - Article

C2 - 18062617

AN - SCOPUS:35848969125

VL - 40

SP - 143

EP - 151

JO - Lymphology

JF - Lymphology

SN - 0024-7766

IS - 3

ER -